Brazil's Hypera to launch an Ozempic generic in 2026, CEO says
By Alberto Alerigi SAO PAULO (Reuters) -Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide ...
There's A Surprising New Side Effect Of Ozempic That Doctors Want You To Know About
A new study links semaglutide, the active ingredient in Ozempic and Wegovy, to a higher risk of hair loss, especially in ...
My hair came out in clumps on a weight loss drug like Ozempic — 2 steps slowed the shedding
Desiree Rodriguez lost 35 pounds on a drug like Ozempic — but the tradeoff was losing “clumps” of her hair. She spoke to The Post about how she managed to minimize the hair loss.
Insurance Coverage For Ozempic, Zepbound Went Down In 2025
While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...
Cheaper, generic versions of Ozempic could come to Canada as early as next year
Four companies have applied to Health Canada to sell copies of Ozempic after its market exclusivity expires on Jan. 4, 2026 ...
Weighing the high cost of obesity reduction drugs
University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity ...
Generic drugmaker races to launch versions of blockbuster obesity drugs
Pharma group Hikma looks to take advantage as Novo Nordisk’s Wegovy and Ozempic start to go off patent next year ...
Devdiscourse1d
Hypera's Ambitious Entry into the Semaglutide Market: A New Dawn for Generics in Brazil
Hypera plans to introduce a generic version of semaglutide in Brazil following patent expiration in 2026. The company is optimistic about market growth despite potential price impacts. Analysts ...
Eli Lilly (LLY) Leads India’s Weight-Loss Drug Race with Mounjaro
Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover ...